Airship Named in 2025 Gartner ® Magic Quadrant™ for Multichannel Marketing Hubs
24.9.2025 18:05:00 EEST | Business Wire | Press release
Airship, the mobile-first customer experience company, today announced its first ever recognition in the 2025 Gartner® Magic Quadrant™ for Multichannel Marketing Hubs1. As a six-time recognized vendor in the Market Guide for Mobile Marketing Platforms2 (formerly known as the Gartner Magic Quadrant for Mobile Marketing Platforms 2018-2020), Airship’s inclusion in Gartner Magic Quadrant for Multichannel Marketing Hubs we feel recognizes its mobile-first expertise in orchestrating seamless cross-channel customer experiences.
Airship believes its inclusion is a validation of its mobile expertise and unique, customer-centric approach that goes beyond cross-channel messaging to optimize the entire customer experience across apps and websites, accelerating conversions, loyalty and business value. Brands face a growing “experience gap” — a disconnect between what mobile-first consumers expect and what brands can deliver. Most platforms focus on orchestrating messages across channels, overlooking a critical reality: conversion and value happen within the experiences on a brand’s app and website.
Gartner notes, ”Every marketing leader should plan for a future of transformative productivity gains in MMH. Faster, cheaper and tailored experiences could open longstanding brands to competitive disruption, enabling small teams to outpace and outperform large marketing orgs, delivering conciergelike customer experiences at cut-rate costs.”
"You don't shape the future by following the crowd,” said Brett Caine, CEO, Airship. “At Airship, we're redefining multichannel marketing by starting where customers actually are — on their mobile device. Airship’s mobile-first platform makes it fast and easy for non-technical teams to optimize every customer journey across apps and websites, creating native, accessible experiences that convert when it matters most. This approach, for us, is strengthened by our recognition in the Gartner Magic Quadrant, is why leading brands choose Airship — we deliver the mobile-first expertise to turn every interaction into lasting value and loyalty.”
Get the full, complimentary report and learn why Airship is recognized in the Gartner Magic Quadrant for Multichannel Marketing Hubs.
Airship’s customers report three major advantages the Airship Experience Platform offers that help them unlock greater business value:
- Seamless, Unified Cross-Channel Experiences: Airship empowers brands to create dynamic, native in-app and web experiences, helping non-technical teams move beyond messaging to create embedded, high-converting app and web content that drives business goals. Leading brands like Ulta Beauty use Airship’s no-code native app experiences to capture customer preferences and deliver tailored recommendations, achieving 2.8 times higher purchase conversion rates compared to customers who did not see these intelligent, personalized experiences. In addition, a SVP of Product at a 30B+ media organization provided a Gartner Peer Insights™ review “Feature-Rich and Reliable Platform: A Comprehensive Analysis” published April 23, 2025, stating, "It [Airship] is a great product offering all the aspects of functionality needed by our division to engage and acquire the mobile audience. Excellent management team, very engaged customer service representative and overall responsive crew. Simply a great product with a great team."
- Hyper-segmentation and Personalization with a Composable Architecture: Brands can go beyond basic analytics to understand their customers on their terms with Airship’s hyper-personalized, in-session app and web experiences that adapt to their behaviors in real-time — driving better outcomes and better data. Easily collect and instantly activate zero-party and behavioral data across customer interactions to become even more precise, effective and respectful over time. The impact is significant and compounds over time. Laurent Claramonte, Head of Data – Mobile Applications, at Orange France stated: "Since moving to Airship’s no-code native app experiences to quickly deploy, test, and adapt onboarding flows, surveys, and more, we now get as many customer survey responses in a day as we used to receive in a month."
- Unparalleled Mobile Expertise and Innovation that Accelerates Time to Value: With a legacy of leading mobile marketing competitive evaluations and pioneering the first commercial push notification, the first in-app message, the first cross-platform mobile wallet passes, and the first Live Activities, new Airship innovations go far beyond expanding mobile audience reach to tap into AI. Airship Journeys AI, Experience Editor and Airship AI Agents build on one another to solve brands’ single biggest obstacle to growth — providing customers the seamless, adaptive experiences they now expect, while eliminating common resource gaps and siloes across teams, channels and data to accelerate brands’ time-to-value. A product management executive from a 3B-10B retailer noted in a Gartner Peer Insights review titled “Robust Platform Driving New Experiences and Increasing Engagement + Revenue,” that “Their [Airship’s] platform is incredibly robust and gives us the ability to drive many new experiences for our users, new channels for our marketing team, and ways to increase revenue by driving user behavior” (published April 1, 2025).
Download a complimentary copy of the 2025 Gartner Magic Quadrant for Multichannel Marketing Hubs report to learn more about why Gartner recognized Airship for the first time in this market.
1 Gartner “Magic Quadrant for Multichannel Marketing Hubs,” by Audrey Brosnan, Tia Smart, Suzanne Schwartz, Greg Carlucci, Julian Poulter, Matt Moorut, Julia Multedo, 22 September 2025
2 Gartner, “Market Guide for Mobile Marketing Platforms,” Suzanne Schwartz, Kassi Socha, 17 February 2025
Gartner Disclaimers
GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, MAGIC QUADRANT and PEER INSIGHTS are registered trademarks of Gartner, Inc. and/or its affiliates and are used herein with permission. All rights reserved.
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
Gartner Peer Insights content consists of the opinions of individual end users based on their own experiences, and should not be construed as statements of fact, nor do they represent the views of Gartner or its affiliates. Gartner does not endorse any vendor, product or service depicted in this content nor makes any warranties, expressed or implied, with respect to this content, about its accuracy or completeness, including any warranties of merchantability or fitness for a particular purpose.
About Airship
Airship is trusted by the world's leading brands such as Alaska Airlines, BBC and The Home Depot for mobile-first expertise powering seamless, cross-channel customer experiences that drive business outcomes and earn customer loyalty.
Airship's mobile-first customer experience platform allows anyone to build, orchestrate and optimize hyper-personalized end-to-end customer journeys across all channels — email, push notifications, SMS, RCS, mobile wallets and more — through to app and web experiences where conversion results in value. Airship's modular network of AI agents accelerate marketing, product and growth teams efforts to continuously enrich customer data and rapidly launch experiments, optimizing every interaction and business outcome — from growing repeatable conversions and customer lifetime value, to fueling durable business growth.
For more information, visit www.airship.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250924438902/en/
Contacts
Media Contacts:
North America:
Kali Myrick Communications
Kali Myrick
+1 503-580-4645
kali@kalimyrick.com
United Kingdom:
Tyto PR
Shamina Peerboccus
+44 7428525900
shamina.peerboccus@tytopr.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom